Syph-Check Syphilis Antibody Point of Care (POC) Test (SyphPoc)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2008 by Healthcare Providers Direct, Inc..
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Healthcare Providers Direct, Inc.
ClinicalTrials.gov Identifier:
NCT00732355
First received: August 8, 2008
Last updated: August 11, 2008
Last verified: August 2008

August 8, 2008
August 11, 2008
October 2008
February 2009   (final data collection date for primary outcome measure)
Identify the sensitivity and specificity of the POC test versus accepted laboratory tests [ Time Frame: end of study ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00732355 on ClinicalTrials.gov Archive Site
Percent positive agreement data will include supplemental test results identified by infection categories and treatment as possible [ Time Frame: end of study ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Syph-Check Syphilis Antibody Point of Care (POC) Test
One-Step Syphilis Point of Care Test for Rapid Immunoassay Screening of Antibodies to Treponema Pallidum

The study is designed to evaluate the performance of a rapid membrane test in a clinic or doctor's office setting to identify potential patients infected with syphilis and compare the results to currently licensed laboratory based tests.

The overall objectives of this study are to determine the performance characteristics of a candidate rapid point-of-care test (Syph-Check cassette format) for Treponema pallidum antibodies in serum, plasma and finger stick whole blood obtained from females and males attending sexually transmitted diseases (STD) clinics, family planning / reproductive health clinics, and physician's office; and to compare the performance of this new, rapid test to currently licensed laboratory based tests, the non-treponemal RPR and a Treponemal ELISA or TPPA test.

Observational
Observational Model: Ecologic or Community
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Point of Care clinics and doctor's office that test routine patients (both male and female), i.e. STD clinics, planned parenthood, pre-marital, blood donors, pre-employment, and general populations from different geographic locations having varying prevalence populations.

Syphilis Serodiagnosis
Device: Syph-Check POC
Rapid membrane test for syphilis antibodies
Other Names:
  • RPR
  • TPPA
  • syphilis
  • I
    known syphilis infected patients
    Intervention: Device: Syph-Check POC
  • U
    presumed uninfected patients
    Intervention: Device: Syph-Check POC
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
600
June 2009
February 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Men and Women will be eligible who:

    1. are 18 years of age or older;
    2. Routine "presumed uninfected" for screening visit, or show symptomatic signs of infection or are asymptomatic but are suspected of infection, and either/or have other STD disease conditions and infections, will be identified.
    3. Pregnant women in the first and third trimester

Exclusion Criteria:

  • are under 18 years of age
  • unwillingness to give consent
Both
18 Years and older
Yes
Contact: Charlotte A Gaydos, Dr.P.H 410-614-0932 cgaydos@jhmi.edu
United States
 
NCT00732355
SY-101
No
Norman Proulx, President
Healthcare Providers Direct, Inc.
Not Provided
Study Director: Gary L Lehnus, Ph.D. Lehnus & Associates Consulting
Healthcare Providers Direct, Inc.
August 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP